WinMEMS Technologies, a joint venture subsidiary with U-GEN Biotechnology Inc., has developed a new technology platform called EMMB(EdgeCode® Multiplex Magnetic Bead) system with our own semiconductor process techniques. This platform can be used for life science researches and IVD (In Vitro Diagnostic Device) applications in the bio-medical industry. Our patented, powerful technology enables you to track down multiple-biomarkers simultaneously, from a few up to 4,096 or even 1 billion types of biomarkers. This platform can be used for both molecular assays (nucleic acid molecules for genomic analysis) or immuno assays (antibodies/antigens for proteomic analysis). EMMB also shows its superior values on both high sensitivity and wide dynamic range performances.

WinMEMS strives to support our customers to gain the competitive advantages in their product development. WinMEMS welcomes you to be our business partner and we make it easy to turn your precious research results into real products!